NASDAQ: EOLS - Evolus, Inc.

Yield per half year: -42.87%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Evolus, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Evolus, Inc.

Evolus, Inc., компания по производству косметических средств, предоставляет медицинскую эстетическую продукцию врачам и их пациентам в Соединенных Штатах. Компания предлагает Jeuveau, запатентованную формулу очищенного ботулинического токсина типа А мощностью 900 килодальтон для временного улучшения внешнего вида межбровных морщин средней и тяжелой степени у взрослых. Он обслуживает рынок самоокупаемой эстетической медицины. Evolus, Inc. была зарегистрирована в 2012 году и имеет штаб-квартиру в Ньюпорт-Бич, Калифорния.

more details
         
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2018-02-08
ISIN US30052C1071
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.evolus.com
Цена ао 12.43
Change price per day: 0% (9.54)
Change price per week: -6.84% (10.24)
Change price per month: -26.39% (12.96)
Change price per 3 month: -2.65% (9.8)
Change price per half year: -42.87% (16.7)
Change price per year: -19.76% (11.89)
Change price per 3 year: -15.05% (11.23)
Change price per 5 year: +160.66% (3.66)
Change price per year to date: -13.9% (11.08)
All parameters

Underestimation

Title Value Grade
P/S 2.81 6
P/BV -27.4 0
P/E 0 0
EV/EBITDA -20.85 0
Total: 3.88

Efficiency

Title Value Grade
ROA, % -32.64 0
ROE, % 298.15 10
Total: 3.33

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -4.03 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % 478.63 10
Yield Ebitda, % -55.03 0
Yield EPS, % -66.01 0
Total: 2
More

ETFShare, %Profitability for 1 year, %Dividends, %
Future Tech ETF 0.1005 426.34 0.8416
Principal Healthcare Innovators ETF 0.1005 618.5 0.8416
iShares Morningstar Small-Cap Growth ETF 0.03476 596.94 0.72598
iShares Morningstar Small-Cap ETF 0.01764 391.25 1.60498
0.06508.261



Head Job title Payment Year of birth
Mr. David Moatazedi President, CEO & Director 1.27M 1978 (47 years)
Ms. Sandra Beaver Chief Financial Officer 372.23k 1978 (47 years)
Dr. Rui Avelar C.CFP, Dip.SportMed, M.D. Chief Medical Officer and Head of Research & Development 682.03k 1962 (63 years)
Mr. Jeffrey J. Plumer General Counsel N/A
Mr. Kurt Knab Vice President of Sales N/A
Ms. Jessica Novak Senior Vice President of Human Resources N/A
Ms. Tomoko Yamagishi-Dressler Chief Marketing Officer N/A
Mr. Nareg Sagherian Head of Global Investor Relations & Corporate Communications N/A

Address: United States, Newport Beach. CA, 520 Newport Center Drive - open in Google maps, open in Yandex maps
Website: https://www.evolus.com